Creative BioTherapeutics is a biotechnology company developing therapies for cancer and viruses.
Creative BioTherapeutics has raised $947K in total funding. The most recent round was Undisclosed. The last funding was announced in February 2023.
Creative BioTherapeutics's investors include National Science Foundation.
Creative BioTherapeutics is headquartered in Gurnee, United States.
Creative BioTherapeutics is a biotechnology company developing therapies for cancer and viruses.
Creative BioTherapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Creative BioTherapeutics — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/creative-biotherapeutics. Accessed August 14, 2026.
VCBacked. (2023). Creative BioTherapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/creative-biotherapeutics
{{cite web |title=Creative BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/creative-biotherapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated